论文部分内容阅读
随着“禁止限制处方外流”政策的明确公布,距离医药分开的医改目标的实现愈来愈近。呼应近3000亿元的新增处方药市场空间,打开市场的钥匙——处方必将成为行业争夺的焦点。但是,因为医药市场的特殊属性,在行政之手与市场之手的共同作用下,外流处方的流向成谜。目前处方的“生产基地”呈现出多元化的特征,既有长期拥有处方独占权的实体医院,又有主导处方分配权的网络医院,且二者逐渐呈现融合趋势,唯有溯源才能真正掌握处方的流转轨迹,继而取得处方的所有权。而从处方的表现形态来看,既有承袭于传统的纸质处方,又有被互联网催生的电子处方,还有
With the explicit prohibition of the policy of “restricting the flow of prescriptions out of prescriptions”, the goal of medical reform that is separated from medicine has become closer and closer. Echoed nearly 300 billion yuan of new prescription drug market space, the key to open the market - the prescription will surely become the focus of competition in the industry. However, because of the special nature of the pharmaceutical market, the flow of prescriptions to outflows is a mystery under the joint action of the executive and the market. At present, the “base of production” of prescriptions shows a variety of characteristics. There are both entity hospitals that have long-term exclusive prescriptions and network hospitals that dominate prescription distribution rights, and the two gradually show the trend of convergence. Only traceability can be truly true Master the circulation of prescriptions, and then obtain the ownership of prescriptions. From the performance of prescription form point of view, both inherited in the traditional paper prescriptions, there are Internet-generated electronic prescription, as well as